RxLegal: Emergency Use Authorizations

被引：0
|
作者：
Gabay, Michael [1 ]
Vora, Niam [1 ]
机构：
[1] Univ Illinois, Chicago, IL 60612 USA
来源：
HOSPITAL PHARMACY | 2023年 / 58卷 / 01期
关键词：
legal aspects; vaccines; COVID;
D O I：
10.1177/00185787221130703
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Emergency use authorizations (EUAs) are a mechanism to allow for the availability and use of medical products during a public health emergency. During the COVID-19 pandemic, hundreds of products have been authorized for use under an EUA. This has led to legal issues-most prominently, the legality of vaccine mandates. Language within the statute that created the EUA pathway has been subject to varying interpretations that could refuse or allow the implementation of EUA vaccine mandates and suits have been filed against organizations that have established vaccine mandates as a term of continued employment.
引用
收藏
页码：16 / 17
页数：2
相关论文
共 50 条
  • [1] Emergency authorizations to use neonicotinoids moved westwards
    不详
    SUGAR INDUSTRY-ZUCKERINDUSTRIE, 2021, 146 (04): : 199 - 199
  • [2] Assessing COVID-19 Emergency Use Authorizations
    Parasidis, Efthimios
    Berman, Micah L.
    Zettler, Patricia J.
    FOOD AND DRUG LAW JOURNAL, 2021, 76 (03) : 441 - 501
  • [3] FDA and Industry Prepare for Transition from Emergency Use Authorizations
    Wechsler, Jill
    Pharmaceutical Technology, 2022, 46 (05) : 14 - 15
  • [4] End of a Declared Public Health Emergency - Implications for US Emergency Use Authorizations
    Marks, Peter W.
    Marston, Hilary D.
    Baden, Lindsey R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (13): : 1153 - 1155
  • [5] FDA and Industry Prepare for Transition from Emergency Use Authorizations
    Wechsler, Jill
    BIOPHARM INTERNATIONAL, 2022, 35 (05) : 8 - 9
  • [6] Emergency Use Authorizations of COVID-19-Related Medical Products
    Moshkovits, Itay
    Shepshelovich, Daniel
    JAMA INTERNAL MEDICINE, 2022, 182 (02) : 228 - 229
  • [7] Acceleration of new medicines–CMC lessons learned from emergency use authorizations
    James Bernstein
    Kim Huynh-Ba
    Patrick Lynch
    Thomas Oliver
    Reza Oliyai
    Scott W. Roberts
    Andrea Schirmer
    David Schwinke
    Kin Tang
    Jessica Ursin
    AAPS Open, 10 (1)
  • [8] Therapeutic Emergency Use Authorizations (EUAs) During Pandemics: Double-edged Swords
    Bhimraj, Adarsh
    Morgan, Rebecca L.
    Shumaker, Amy Hirsch
    Lavergne, Valery
    Baden, Lindsey
    Cheng, Vincent Chi-Chung
    Edwards, Kathryn M.
    Gandhi, Rajesh T.
    Gallagher, Jason C.
    Muller, William J.
    O'Horo, John C.
    Shoham, Shmuel
    Wollins, Dana Swartzberg
    Falck-Ytter, Yngve
    CLINICAL INFECTIOUS DISEASES, 2022, 74 (09) : 1686 - 1690
  • [9] The evidence base for emergency use authorizations for COVID-19 treatments: A rapid review
    Knowlson, Catherine
    Byrne, Ailish
    Wilkinson, Jacqueline
    Whitmore, Claire
    Torgerson, David
    HEALTH SCIENCE REPORTS, 2023, 6 (01)
  • [10] Health Equity and Access to COVID-19 Treatments Available through Emergency Use Authorizations
    Johnson, Candon
    Wolff, Carolyn
    Xu, Jing
    JOURNAL OF RACIAL AND ETHNIC HEALTH DISPARITIES, 2024,
12345